Left ventricular ejection fraction is determined by both global myocardial strain and wall thickness

IJC Heart and Vasculature

Volumn 7, Issue , 2015, Pages 113-118

  MacIver, David H ^a,b,c   Adeniran, Ismail ^a   Zhang, Henggui ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Ejection fraction; Heart failure; Mathematical modelling; Pathophysiology

Indexed keywords

ARTICLE; BIOMECHANICS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CURVE FITTING; GLOBAL MYOCARDIAL STRAIN; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HUMAN; MATHEMATICAL MODEL; PATHOPHYSIOLOGY; SIMULATION;

EID: 84930618622     PISSN: 23529067     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcha.2015.03.007     Document Type: Article

References (59)

1. Mizuguchi Y., Oishi Y., Miyoshi H., Iuchi A., Nagase N., Oki T. Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function. J Cardiol 2010, 55:23-33.
2. Delgado V., Tops L.F., van Bommel R.J., van der Kley F., Marsan N.A., Klautz R.J., et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J 2009, 30:3037-3047.
3. Serri K., Reant P., Lafitte M., Berhouet M., Le Bouffos V., Roudaut R., et al. Global and regional myocardial function quantification by two-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006, 47:1175-1181.
4. Wang J., Khoury D.S., Yue Y., Torre-Amione G., Nagueh S.F. Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 2008, 29:1283-1289.
5. Kraigher-Krainer E., Shah A.M., Gupta D.K., Santos A., Claggett B., Pieske B., et al. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 2014, 63:447-456.
6. Tan Y.T., Wenzelburger F., Lee E., Heatlie G., Leyva F., Patel K., et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol 2009, 54:36-46.
7. Yip G.W., Zhang Q., Xie J.M., Liang Y.J., Liu Y.M., Yan B., et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart 2011, 97:287-294.
8. MacIver D.H. Current controversies in heart failure with a preserved ejection fraction. Future Cardiol 2010, 6:97-111.
9. Koh Y.S., Jung H.O., Park M.W., Baek J.Y., Yoon S.G., Kim P.J., et al. Comparison of left ventricular hypertrophy, fibrosis and dysfunction according to various disease mechanisms such as hypertension, diabetes mellitus and chronic renal failure. J Cardiovasc Ultrasound 2009, 17:127-134.
10. Shimizu G., Hirota Y., Kita Y., Kawamura K., Saito T., Gaasch W.H. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991, 83:1676-1684.
11. Vinch C.S., Aurigemma G.P., Simon H.U., Hill J.C., Tighe D.A., Meyer T.E. Analysis of left ventricular systolic function using midwall mechanics in patients>60years of age with hypertensive heart disease and heart failure. Am J Cardiol 2005, 96:1299-1303.
12. Aurigemma G.P., Silver K.H., Priest M.A., Gaasch W.H. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995, 26:195-202.
13. de Simone G., Devereux R.B., Roman M.J., Ganau A., Saba P.S., Alderman M.H., et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994, 23:1444-1451.
14. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
15. Schillaci G., Vaudo G., Pasqualini L., Reboldi G., Porcellati C., Verdecchia P. Left ventricular mass and systolic dysfunction in essential hypertension. J Hum Hypertens 2002, 16:117.
16. Perlini S., Salinaro F., Musca F., Mussinelli R., Boldrini M., Raimondi A., et al. Prognostic value of depressed midwall systolic function in cardiac light-chain amyloidosis. J Hypertens 2014, 32. [Published ahead of print].
17. De Keulenaer G.W., Brutsaert D.L. Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum. Circulation 2011, 123:1996-2004.
18. MacIver D.H., Townsend M. A novel mechanism of heart failure with normal ejection fraction. Heart 2008, 94:446-449.
19. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948-1955.
20. Volpi A., De Vita C., Franzosi M.G., Geraci E., Maggioni A.P., Mauri F., et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the Gissi-2 data base. The Ad Hoc Working Group of the Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'infarto Miocardico (Gissi)-2 Data Base. Circulation 1993, 88:416-429.
21. Puma J.A., Sketch M.H., Thompson T.D., Simes R.J., Morris D.C., White H.D., et al. Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. Am J Cardiol 1999, 83:482-487.
22. Curtis J.P., Sokol S.I., Wang Y., Rathore S.S., Ko D.T., Jadbabaie F., et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol 2003, 42:736-742.
23. Barbieri A., Bursi F., Mantovani F., Valenti C., Quaglia M., Berti E., et al. Left ventricular hypertrophy reclassification and death: application of the recommendation of the American Society of Echocardiography/European Association of Echocardiography. Eur Heart J Cardiovasc Imaging 2012, 13:109-117.
24. Schillaci G., Verdecchia P., Porcellati C., Cuccurullo O., Cosco C., Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000, 35:580.
25. Devereux R.B., Wachtell K., Gerdts E., Boman K., Nieminen M.S., Papademetriou V., et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004, 292:2350-2356.
26. Ghali J.K., Liao Y., Simmons B., Castaner A., Cao G., Cooper R.S. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992, 117:831-836.
27. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991, 114:345.
28. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
29. Quinones M.A., Greenberg B.H., Kopelen H.A., Koilpillai C., Limacher M.C., Shindler D.M., et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD Registry and Trials: significance of left ventricular hypertrophy. Studies of left ventricular dysfunction. J Am Coll Cardiol 2000, 35:1237-1244.
30. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
31. Owan T., Hodge D., Herges R., Jacobsen S., Roger V., Redfield M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
32. Stanton T., Leano R., Marwick T.H. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2009, 2:356-364.
33. Cho G.-Y., Marwick T.H., Kim H.-S., Kim M.-K., Hong K.-S., Oh D.-J. Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009, 54:618-624.
34. Su H.M., Lin T.H., Hsu P.C., Lee W.H., Chu C.Y., Lee C.S., et al. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart 2013, 99:1588-1596.
35. MacIver D.H. Understanding myocardial deformation, 'global systolic function' and abnormal geometry. Heart 2009, 10.1136/hrt.2009.172569.
36. MacIver D.H. A new method for quantification of left ventricular systolic function using a corrected ejection fraction. Eur J Echocardiogr 2011, 12:228-234.
37. MacIver D.H. The relative impact of circumferential and longitudinal shortening on left ventricular ejection fraction and stroke volume. Exp Clin Cardiol 2012, 17:5-11.
38. MacIver D.H. Is remodeling the dominant compensatory mechanism in both chronic heart failure with preserved and reduced left ventricular ejection fraction?. Basic Res Cardiol 2010, 105:227-234.
39. MacIver D.H., Dayer M.J. An alternative approach to understanding the pathophysiological mechanisms of chronic heart failure. Int J Cardiol 2012, 154:102-110.
40. MacIver D.H., Dayer M.J., Harrison A.J. A general theory of acute and chronic heart failure. Int J Cardiol 2013, 165:25-34.
41. Ky B., Plappert T., Kirkpatrick J., Silvestry F.E., Ferrari V.A., Keane M.G., et al. Left ventricular remodeling in human heart failure: quantitative echocardiographic assessment of 1,794 patients. Echocardiography 2012, 29:758-765.
42. MacIver D.H. A mathematical model of left ventricular contraction and its application in heart disease. Repair and redesign of physiological systems 2008, 65-86. WIT Press, Boston. M. Atherton, M. Collins, M. Dayer (Eds.).
43. Folland E.D., Parisi A.F., Moynihan P.F., Jones D.R., Feldman C.L., Tow D.E. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques. Circulation 1979, 60:760-766.
44. Wyatt H.L., Heng M.K., Meerbaum S., Gueret P., Hestenes J., Dula E., et al. Cross-sectional echocardiography. II. Analysis of mathematic models for quantifying volume of the formalin-fixed left ventricle. Circulation 1980, 61:1119-1125.
45. Wyatt H.L., Heng M.K., Meerbaum S., Hestenes J.D., Cobo J.M., Davidson R.M., et al. Cross-sectional echocardiography. I. Analysis of mathematic models for quantifying mass of the left ventricle in dogs. Circulation 1979, 60:1104-1113.
46. Emilsson K., Egerlid R., Nygren B.M., Wandt B. Mitral annulus motion versus long-axis fractional shortening. Exp Clin Cardiol 2006, 11:302-304.
47. Emilsson K., Brudin L., Wandt B. The mode of left ventricular pumping: is there an outer contour change in addition to the atrioventricular plane displacement?. Clin Physiol 2001, 21:437-446.
48. Zhu Y., Papademetris X., Sinusas A.J., Duncan J.S. A coupled deformable model for tracking myocardial borders from real-time echocardiography using an incompressibility constraint. Med Image Anal 2010, 14:429-448.
49. MacIver D.H. a new understanding and definition of non-compaction cardiomyopathy using analysis of left ventricular wall mechanics and stresses. Int J Cardiol 2014, 174:819-821.
50. Maurer M.S., Burkhoff D., Fried L.P., Gottdiener J., King D.L., Kitzman D.W. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol 2007, 49:972-981.
51. Maurer M.S., King D.L., El-Khoury R.L., Packer M., Burkhoff D. Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms. J Card Fail 2005, 11:177-187.
52. Casey H., Dastidar A.G., MacIver D.H. Swimming induced pulmonary oedema in two triathletes: a novel pathophysiological explanation. J R Soc Med 2014, [in press]. 10.1177/0141076814543214.
53. MacIver D.H. The impact of mitral regurgitation on left ventricular ejection fraction using mathematical modelling. Exp Clin Cardiol 2014, 20:4994-5008.
54. Carreras F., Garcia-Barnes J., Gil D., Pujadas S., Li C.H., Suarez-Arias R., et al. Left ventricular torsion and longitudinal shortening: two fundamental components of myocardial mechanics assessed by tagged cine-MRI in normal subjects. Int J Cardiovasc Imaging 2011, 1-12.
55. Sievers B., Kirchberg S., Bakan A., Franken U., Trappe H.J. Impact of papillary muscles in ventricular volume and ejection fraction assessment by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2004, 6:9-16.
56. Foley T.A., Mankad S.V., Anavekar N.S., Bonnichsen C.R., Morris M.F., Miller T.D., et al. Measuring Left ventricular ejection fraction - techniques and potential pitfalls. Eur Cardiol 2012, 8:108-114.
57. Adeniran I., MacIver D.H., Hancox J.C., Zhang H. Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile function and incomplete relaxation: An electromechanically detailed biophysical modelling study. Frontiers Physiology 2015, 6(78):1-14.
58. Adeniran I., MacIver D.H., Zhang H. Myocardial electrophysiological, contractile and metabolic properties of hypertrophic cardiomyopathy: Insights from modelling. Comput Cardiol. 2014, 41:1037-1040.
59. MacIver D.H., Clark A.L. The vital role of the right ventricle in the pathogenesis of acute pulmonary edema. The Am J Cardiol 2015, 115(7):992-1000.